
PRI Insider (Volume 5, Issue 15) May 2
In This Issue: The Ethics and Public Policy Center (EPPC) has exposed the true dangers of the abortion drug mifepristone. The EPPC recently released the largest-known study on this abortion pill, analyzing data from 865,727 abortions between 2017 and 2023. The study found that 10.93% of women experienced serious adverse events—such as sepsis, infection, or hemorrhage—within 45 days of taking the drug, a rate at least 22 times higher than what clinical trials reported.








